Investors

Press Releases

Nov 17, 2023
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
Keep Reading
Nov 14, 2023
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
Keep Reading
Nov 13, 2023
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
Keep Reading
Nov 08, 2023
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Keep Reading
Nov 02, 2023
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
Keep Reading
Oct 31, 2023
Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
Keep Reading
Oct 05, 2023
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
Keep Reading
Oct 03, 2023
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
Keep Reading
Sep 27, 2023
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
Keep Reading
Sep 05, 2023
Twist Bioscience to Present at Upcoming Investor Conferences
Keep Reading